Clarithromycin is an advanced macrolide antibiotic, structurally related to erythromycin but with improved acid stability and a broader spectrum of activity. It is widely utilised for treating various respiratory tract infections, skin infections, and plays a pivotal, indispensable role as a core component in multidrug regimens aimed at eradicating Helicobacter pylori (H. pylori) to treat peptic ulcer disease.